AYOKI MERCANTILE LTD.

Wardwizard Healthcare Ltd has issued a corrigendum to the notice of its 42nd Annual General Meeting (AGM), scheduled for September 30, 2026. This corrigendum clarifies the object of a preferential issue of fully convertible warrants. Specifically, it details an investment of ₹8 Crores in Wardwizard Medicare Private Limited (WMPL) via subscription to 2% Non-Cumulative Convertible Preference Shares. The funds will support WMPL's growth and expansion in its healthcare business, which includes operating four hospitals and an Ayurvedic center. The company confirms the entire amount will be invested solely in WMPL and not used for loan repayments.

Wardwizard Healthcare Ltd has announced its 42nd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 3:00 PM IST via Video Conferencing. The company is dispatching letters to shareholders who have not registered their email addresses, providing a web link to the Annual Report for FY 2025-26 and the AGM Notice. This communication also serves as a reminder for KYC updates and dematerialization of physical securities as per SEBI mandates.

Wardwizard Healthcare Ltd has announced the book closure for its 42nd Annual General Meeting (AGM). The Register of Members and Register of Transfers will be closed from September 23, 2026, to September 30, 2026, inclusive. The AGM is scheduled for September 30, 2026, at 3:00 p.m. via Video Conferencing/Other Audio Visual Means. Members will have the facility to vote remotely or during the AGM. The cut-off date for voting eligibility is September 21, 2026. The Board of Directors has not recommended any dividend for the year.

Wardwizard Healthcare Ltd has submitted the notice for its 42nd Annual General Meeting (AGM) and the Annual Report for the Financial Year 2025-26. The AGM is scheduled for Wednesday, September 30, 2026, at 15:00 IST, to be conducted via Video Conferencing. The Annual Report, available on the company's website, includes the Notice of AGM, Directors' Report, Auditors' Reports, and Audited Financial Statements for the fiscal year ending March 31, 2026. The company emphasizes its vision of making healthcare affordable and accessible, operating across allopathy and ayurveda divisions.

Wardwizard Healthcare Ltd has announced its 42nd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The cut-off date for determining eligibility to vote is Monday, September 21, 2026. Remote e-voting will be open from Sunday, September 27, 2026, at 9:00 AM IST to Tuesday, September 29, 2026, at 5:00 PM IST. Key agenda items include the adoption of the audited standalone financial statements for the fiscal year ended March 31, 2026, the re-appointment of Mr. Yatin Sanjay Gupte as a Director, and the regularization of the appointment of M/s. MGSA & Company as statutory auditors to fill a casual vacancy.

Wardwizard Healthcare Ltd announced the appointment of two new directors to its Board of Directors following a meeting on August 31, 2026. Ms. Sathi Kundu has been appointed as an Additional Independent Woman Director for a term of 5 years, effective August 31, 2026. Mr. Yuvraj Priyadarshi, who was previously appointed as an Additional Director and CEO, has had his appointment as Whole-time Director approved, effective September 30, 2026, subject to shareholder approval. Both appointments are in compliance with SEBI regulations.

Wardwizard Healthcare Ltd's Board of Directors has approved the issuance of up to 1,25,00,000 fully convertible warrants on a preferential basis. The warrants will be issued at ₹10 per warrant, aggregating up to ₹12,50,00,000. Each warrant is convertible into one equity share of face value ₹10. The issuance is subject to shareholder and regulatory approvals. The warrants are convertible within 18 months of allotment, with unconverted warrants and subscription amounts subject to forfeiture. Proposed allottees include promoters Yatin Sanjay Gupte and Sheetal Mandar Bhalerao, along with several non-promoter group entities.

Wardwizard Healthcare Ltd announced a significant increase in its authorized share capital. The company's Board of Directors approved the proposal to raise the authorized capital from ₹7.50 Crores to ₹25 Crores. This expansion involves increasing the number of equity shares from 75 Lakh to 2.50 Crore, each with a face value of ₹10. The revised capital structure will be reflected in the company's Memorandum of Association. This move is likely to facilitate future growth and funding opportunities for the company.

Wardwizard Healthcare Ltd's Board of Directors met on August 31, 2026, to approve a significant increase in the company's authorized share capital from ₹7.50 Crores to ₹25 Crores. The board also approved the preferential issue of up to 1,25,00,000 warrants, convertible into equity shares, aggregating up to ₹12.50 Crores. Additionally, Ms. Sathi Kundu was appointed as an Additional Director (Independent Director) for a five-year term.

Wardwizard Healthcare Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective August 24, 2026. This closure is in compliance with SEBI (PIT) Regulations, 2015, and the company's insider trading code. The window will reopen 48 hours after the board meeting scheduled for August 31, 2026. The board meeting agenda includes considering and approving a proposal for fund raising and increasing the authorized share capital.